Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Clinical trial NCT06253546 · COMPLETED
Trial details
- NCT number
- NCT06253546
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2025-06-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.